Literature DB >> 10951119

Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle.

J Lynge1, Y Hellsten.   

Abstract

Many important physiological functions of skeletal muscle, such as glucose uptake, contraction and blood flow, have been proposed to be regulated via the action of adenosine on adenosine receptors. The cellular location of adenosine receptors in skeletal muscle is however, not known. The present study examined the distribution of A1, A2A and A2B adenosine receptors in human skeletal muscle using immunohistochemistry. All three receptor types were localized to vascular smooth muscle and endothelial cells, only the adenosine A2A and A2B receptors were observed in the plasma membrane and cytosol of the skeletal muscle. The finding was supported by results from western-blotting analysis. The cytosolic staining of the adenosine A2A receptor was slightly more intense in the type I muscle fibres, whereas the A2B receptor was almost absent in type I fibres. The present findings demonstrate for the first time, direct evidence for the existence of A2A and A2B adenosine receptors but absence of the A1 receptor in the sarcolemma and cytosol of skeletal muscle cells. The data also show existence of all three of the A1, A2A and A2B adenosine receptors in vascular cells of skeletal muscle tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951119     DOI: 10.1046/j.1365-201x.2000.00742.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  30 in total

1.  Binding of adenosine receptor ligands to brain of adenosine receptor knock-out mice: evidence that CGS 21680 binds to A1 receptors in hippocampus.

Authors:  Linda Halldner; Luisa V Lopes; Elisabetta Daré; Karin Lindström; Björn Johansson; Catherine Ledent; Rodrigo A Cunha; Bertil B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-18       Impact factor: 3.000

2.  Pre-exposure to adenosine, acting via A(2A) receptors on endothelial cells, alters the protein kinase A dependence of adenosine-induced dilation in skeletal muscle resistance arterioles.

Authors:  Nir Maimon; Patricia A Titus; Ingrid H Sarelius
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

Review 3.  Local control of blood flow during active hyperaemia: what kinds of integration are important?

Authors:  Coral L Murrant; Ingrid H Sarelius
Journal:  J Physiol       Date:  2015-09-29       Impact factor: 5.182

Review 4.  The roles of adenosine and related substances in exercise hyperaemia.

Authors:  Janice M Marshall
Journal:  J Physiol       Date:  2007-07-05       Impact factor: 5.182

5.  The Effects of the Adenosine Receptor Antagonists on the Reverse of Cardiovascular Toxic Effects Induced by Citalopram In-Vivo Rat Model of Poisoning.

Authors:  Müjgan Büyükdeligöz; Nil Hocaoğlu; Kubilay Oransay; Yeşim Tunçok; Şule Kalkan
Journal:  Balkan Med J       Date:  2015-07-01       Impact factor: 2.021

Review 6.  Contribution of intravascular versus interstitial purines and nitric oxide in the regulation of exercise hyperaemia in humans.

Authors:  Y Hellsten; M Nyberg; S P Mortensen
Journal:  J Physiol       Date:  2012-06-25       Impact factor: 5.182

7.  Adenosine A2B and A3 receptor location at the mouse neuromuscular junction.

Authors:  Neus Garcia; Mercedes Priego; Erica Hurtado; Teresa Obis; Manel M Santafe; Marta Tomàs; Maria Angel Lanuza; Josep Tomàs
Journal:  J Anat       Date:  2014-04-23       Impact factor: 2.610

8.  Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters.

Authors:  J Lynge; C Juel; Y Hellsten
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

9.  Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment.

Authors:  Rosely Oliveira Godinho; Valter Luiz Costa
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

10.  Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.

Authors:  T Chiavegatti; V L Costa; M S Araújo; R O Godinho
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.